Kyle Blankenship, the managing editor of biopharmaceutical news outlet Endpoints News, is leaving for a non-journalism job.
His last day is Friday.
Blankenship has been at Endpoints since December 2020, first as a senior editor. He has been managing editor since February 2021.
He previously worked as an associate editor at FiercePharma, as a city editor and investigations reporter at the Killeen Daily Herald in Texas and as a copy editor of the Bryan-College Station Eagle, also in Texas.
Blankenship holds a master’s degree from the University of North Texas and a bachelor’s degree from Texas A&M University.
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…